Pharmaceutical Executive September 13, 2021
Mark Davies and Paul Riley describe their a blueprint for exploring how healthcare companies can leverage real world evidence to access and engage customers more effectively.
The not-so-simple challenge of brands and real-world evidence
Real-world evidence (RWE) is defined as “the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from analysis of real-world data,” with real world data being “the data relating to patient health status and/or delivery of healthcare routinely collected from a variety of sources, including product and disease registries, patient-generated data including in home use settings, case studies and information collected from other health-related sources such as apps on mobile phones.”1
A review commissioned by the UK government highlighted that...